CD40DNA Vax

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCD40DNA Vax
Drug Alias NameDNA-based dendritic cell vaccine (The Children's Hospital at Westmead/Westmead Millennium Institute for Medical Research/Bio-Link)CD40 DNA vaccine (The Children's Hospital at Westmead/Westmead Millennium Institute for Medical Research/Bio-Link)
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapyVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine +[4] 
Mechanisms of ActionTumor necrosis factor receptor superfamily member 5 inhibitors
TargetsTumor necrosis factor receptor superfamily member 5
Therapy Area/IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Children's Hospital at Westmead
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBio-Link Australia Pty LtdWestmead Institute for Medical ResearchThe Children's Hospital at Westmead
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantationHypersensitivityAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A